We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+13.2%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.87B
AUM Growth
+$356M
Cap. Flow
-$28.2M
Cap. Flow %
-0.48%
Top 10 Hldgs %
37.62%
Holding
149
New
49
Increased
32
Reduced
27
Closed
36

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$191M
2
UAL icon
United Airlines
UAL
+$156M
3
DAL icon
Delta Air Lines
DAL
+$150M
4
VER
VEREIT, Inc.
VER
+$127M
5
FNF icon
Fidelity National Financial
FNF
+$120M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$382M
2
MPC icon
Marathon Petroleum
MPC
+$200M
3
PXD
Pioneer Natural Resource Co.
PXD
+$162M
4
LNG icon
Cheniere Energy
LNG
+$143M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$128M

Sector Composition

Rank Sector Weight
1 Healthcare 24.02%
2 Industrials 20.86%
3 Energy 10.85%
4 Consumer Discretionary 8.31%
5 Technology 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCD icon
51
McDonald's
MCD
$193B
$32.8M 0.56%
+350,000
New +$32.8M
TTPH
52
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$31.8M 0.54%
40,000
+25,000
+167% +$13.5M
LEA icon
53
Lear
LEA
$7.39B
$30.4M 0.52%
310,400
+300,600
+3,067% +$27.6M
WMGI
54
DELISTED
Wright Medical Group Inc
WMGI
$25.5M 0.43%
950,000
+50,000
+6% +$1.46M
TWC
55
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$24.9M 0.42%
+163,700
New +$23.6M
BMRN icon
56
BioMarin Pharmaceuticals
BMRN
$11.9B
$24.9M 0.42%
+275,000
New +$22.9M
WFC icon
57
Wells Fargo
WFC
$254B
$24.7M 0.42%
+450,700
New +$23.9M
PAGP icon
58
Plains GP Holdings
PAGP
$5.28B
$22.2M 0.38%
323,920
+314,532
+3,350% +$22.3M
DD icon
59
DuPont de Nemours
DD
$18.6B
$22M 0.37%
+190,056
New +$23.2M
LH icon
60
Labcorp
LH
$25.2B
$21.6M 0.37%
+232,800
New +$20.6M
DHR icon
61
Danaher
DHR
$138B
$20.3M 0.35%
351,872
-432,811
-55% -$23.5M
LUMO
62
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$19.9M 0.34%
55,667
-69,333
-55% -$20.6M
AXLL
63
DELISTED
AXIALL CORP COM STK (DE)
AXLL
$19.5M 0.33%
+459,528
New +$18.7M
LTRPA
64
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$19.2M 0.33%
+715,000
New +$19.8M
KYNB
65
Kyntra Bio
KYNB
$27.4M
$19.2M 0.33%
+35,165
New +$22.6M
CELG
66
DELISTED
Celgene Corp
CELG
$16.8M 0.29%
+150,000
New +$15.8M
NBIX icon
67
Neurocrine Biosciences
NBIX
$18.2B
$16.8M 0.29%
+750,000
New +$14.2M
NKTR icon
68
Nektar Therapeutics
NKTR
$2.39B
$15.5M 0.26%
+66,667
New +$14.2M
ALSN icon
69
Allison Transmission
ALSN
$9.51B
$15.2M 0.26%
448,887
-2,813,446
-86% -$89.6M
IBB icon
70
iShares Biotechnology ETF
IBB
$9.45B
$15.2M 0.26%
+150,000
New +$14.6M
HLT icon
71
Hilton Worldwide
HLT
$72.4B
$14.5M 0.25%
+184,967
New +$13.9M
AVNS icon
72
Avanos Medical
AVNS
$13.6M 0.23%
+300,000
New +$11.8M
AMAG
73
DELISTED
AMAG Pharmaceuticals
AMAG
$13.2M 0.23%
310,000
+250,000
+417% +$9.03M
MGNX icon
74
MacroGenics
MGNX
$233M
$13.2M 0.22%
375,000
+275,000
+275% +$6.86M
JAZZ icon
75
Jazz Pharmaceuticals
JAZZ
$16.1B
$13.1M 0.22%
80,000
+5,000
+7% +$830K
1 2
3
4 5

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
MT
Midwest Trust Overland Park, Kansas $8.02B AUM 23.54% 1-Year Est. Return

PointState Capital's Q4 2014 Portfolio in Review

As of Q4 2014, PointState Capital held 149 positions worth $5.87B, up 6.4% from $5.52B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

PointState Capital's Q4 2014 filing shows 49 new, 32 increased, 27 reduced and 36 closed positions. Its largest new stake was RTX Corp: 2,807,127 shares worth $203M. The largest sale was AbbVie, an estimated $382M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Industrials and Energy.

  • PointState Capital's largest Q4 2014 buy was RTX Corp: 2,807,127 shares worth $203M.
  • PointState Capital added most to United Airlines in Q4 2014, an estimated $156M increase.
  • PointState Capital's biggest Q4 2014 reduction was AbbVie, cutting an estimated $382M.
  • PointState Capital fully exited Marathon Petroleum in Q4 2014, selling an estimated $200M.
  • PointState Capital's ten largest holdings make up 38% of its $5.87B portfolio in Q4 2014.
  • PointState Capital opened 49 new positions and closed 36 in Q4 2014.
  • PointState Capital's portfolio value rose 6.4% quarter-over-quarter to $5.87B.

Based on PointState Capital's 13F filing for Q4 2014, filed 17 Feb 2015.